1Life Healthcare (NASDAQ:ONEM) Price Target Lowered to $11.00 at Deutsche Bank Aktiengesellschaft

1Life Healthcare (NASDAQ:ONEMGet Rating) had its price target decreased by Deutsche Bank Aktiengesellschaft from $16.00 to $11.00 in a research note published on Friday morning, The Fly reports.

Other analysts also recently issued research reports about the stock. Citigroup reduced their price target on shares of 1Life Healthcare from $17.00 to $14.00 in a research report on Thursday, May 5th. William Blair reissued an outperform rating on shares of 1Life Healthcare in a research report on Thursday, March 10th. SVB Leerink reduced their price target on shares of 1Life Healthcare from $24.00 to $10.00 and set a market perform rating for the company in a research report on Thursday, February 24th. Guggenheim started coverage on 1Life Healthcare in a research note on Tuesday, March 29th. They set a neutral rating on the stock. Finally, Zacks Investment Research upgraded 1Life Healthcare from a hold rating to a buy rating and set a $8.50 price objective on the stock in a research note on Wednesday, May 4th. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of Buy and an average price target of $21.97.

Shares of ONEM stock opened at $6.73 on Friday. The firm has a 50 day moving average of $9.59 and a 200-day moving average of $13.52. 1Life Healthcare has a 52 week low of $6.55 and a 52 week high of $41.41. The company has a quick ratio of 3.00, a current ratio of 3.03 and a debt-to-equity ratio of 0.18. The company has a market cap of $1.30 billion, a price-to-earnings ratio of -3.78 and a beta of 1.87.

1Life Healthcare (NASDAQ:ONEMGet Rating) last posted its quarterly earnings results on Wednesday, May 4th. The company reported ($0.47) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.49) by $0.02. 1Life Healthcare had a negative net margin of 40.50% and a negative return on equity of 23.03%. The business had revenue of $254.10 million during the quarter, compared to the consensus estimate of $246.57 million. During the same quarter last year, the firm posted ($0.29) EPS. 1Life Healthcare’s revenue was up 109.4% compared to the same quarter last year. Analysts anticipate that 1Life Healthcare will post -1.93 earnings per share for the current year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Rhenman & Partners Asset Management AB raised its stake in shares of 1Life Healthcare by 27.3% during the 3rd quarter. Rhenman & Partners Asset Management AB now owns 420,000 shares of the company’s stock worth $8,505,000 after purchasing an additional 90,000 shares during the period. Nikko Asset Management Americas Inc. increased its holdings in 1Life Healthcare by 12.1% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 774,516 shares of the company’s stock worth $12,415,000 after acquiring an additional 83,760 shares during the last quarter. WCM Investment Management LLC increased its holdings in 1Life Healthcare by 5.6% in the 4th quarter. WCM Investment Management LLC now owns 393,412 shares of the company’s stock worth $6,912,000 after acquiring an additional 20,778 shares during the last quarter. Must Asset Management Inc. increased its holdings in 1Life Healthcare by 791.0% in the 3rd quarter. Must Asset Management Inc. now owns 112,233 shares of the company’s stock worth $2,245,000 after acquiring an additional 99,637 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ increased its holdings in 1Life Healthcare by 5.5% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 39,277 shares of the company’s stock worth $795,000 after acquiring an additional 2,046 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

About 1Life Healthcare (Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

Recommended Stories

The Fly logo

Analyst Recommendations for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.